Retinopathy of Prematurity is a potentially devastating disease that necessitates frequent, intensive screening of premies. Now, MLI (formerly Massie Labs) is touting data for their RetCam imaging system, as an effective remedy:
In the prospective, multicenter PhotoROP study, infants were examined at bedside with the current imaging standard (indirect ophthalmoscope) and remotely with the RetCam™ Digital Imaging System. The study sought to detect clinically significant ROP (CSROP), in other words, ROP that warranted referral to a pediatric eye specialist for potential treatment. Using the RetCam, researchers accurately diagnosed CSROP in 100% of patients as detected by indirect ophthalmoscopy. Furthermore, the condition was identified on average 1 to 2 weeks earlier than with the standard technique…
The RetCam is a unique integrated system that combines first-ever bedside wide-angle viewing, full resolution image selection from real-time digital video with a comprehensive relational database. The availability of an immediate image means that precise diagnostic comparisons can be made over time, rather than relying on inexact drawings in a patient’s chart. The digital capability also enables remote image transfer, so that the clinician no longer needs to be in the same room, or even the same country, as the patient.
More at MLI…